Common Contracts

6 similar null contracts by Precision Therapeutics Inc, Cyberkinetics Neurotechnology Systems, Inc., Immunicon Corp, Transmedics Inc

Contract
Transmedics Inc • September 14th, 2007 • Delaware

NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO SALE OR DISPOSITION MAY BE EFFECTED EXCEPT IN COMPLIANCE WITH RULE 144 UNDER SAID ACT OR WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR THE HOLDER, SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT OR RECEIPT OF A NO-ACTION LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION.

AutoNDA by SimpleDocs
WARRANT TO PURCHASE 125,000 SHARES OF COMMON STOCK September 25, 2002
Precision Therapeutics Inc • August 24th, 2007 • Delaware

THIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase One Hundred Twenty Five Thousand (125,000) shares(1) of the fully paid and nonassessable Common Stock (the “Shares” or the “Stock”) of Precision Therapeutics, Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth.

WARRANT TO PURCHASE 7,955 SHARES OF COMMON STOCK August 18, 2006
Precision Therapeutics Inc • August 24th, 2007 • Connecticut

THIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase Seven Thousand Nine Hundred Fifty-Five (7,955) shares of the fully paid and nonassessable Common Stock (the “Shares” or the “Stock”) of Precision Therapeutics, Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth.

WARRANT TO PURCHASE 26,000 SHARES OF COMMON STOCK
Precision Therapeutics Inc • August 24th, 2007 • Delaware

THIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase Twenty-Six Thousand (26,000) shares of the fully paid and nonassessable Common Stock (the “Shares” or the “Stock”) of Precision Therapeutics, Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth.

WARRANT TO PURCHASE 71,301 SHARES OF COMMON STOCK December 27, 2005
Cyberkinetics Neurotechnology Systems, Inc. • December 27th, 2005 • Surgical & medical instruments & apparatus • Delaware

THIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase Seventy-One Thousand Three Hundred One (71,301) shares of the fully paid and nonassessable Common Stock (the “Shares” or the “Stock”) of Cyberkinetics Neurotechnology Systems, Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth.

WARRANT TO PURCHASE 31,250 SHARES OF COMMON STOCK April 28, 2003
Immunicon Corp • December 8th, 2003 • Connecticut

THIS CERTIFIES THAT, for value received, General Electric Capital Corporation ("Holder") is entitled to subscribe for and purchase Thirty One Thousand Two Hundred Fifty (31,250) shares of the fully paid and nonassessable Common Stock (the "Shares" or the "Stock") of Immunicon Corporation, a Delaware corporation (the "Company"), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!